Save! Risk of academic marketing dead-end trap.docVIP

 PAGE \* MERGEFORMAT 13 Save! Risk of academic marketing dead-end trap Case: Tianhong Pharmaceuticals, Inc. is an early product of academic marketing From EMKT. onto the road business. However, the company after three years of academic marketing attempts and development, product sales and business case not only has not risen, but constantly declining. When the academic marketing into the third year after the completion of the sale the amount of product throughout the year just 30% and 40 between the two. If we say that from the relationship marketing into the marketing of specialized academic Tianhong pharmaceutical companies is a challenge, it is very tough first year, but the companies will operate for three years of academic marketing, product sales but this is not satisfactory is not normal. So what causes the Tianhong academic marketing pharmaceutical companies it is almost into a dead end? Later, after understanding and analysis found that the academic Tian pharmaceutical companies marketing in three years of operation were simply not professional, and was not able to exactly as many early and left a number of academic medicine foreign marketing, as the product sales showed great vitality. Although the current academic marketing is no longer a ‘Spring Snow’, but if the system such as the Tian-local pharmaceutical companies be able to learn from real-world experience, while foreign companies and to carry out improvement and innovation, the marketing of ‘exotic’ coated with more local color, then it is not academic marketing up until this point. Tianhong Pharmaceutical Although the costs do invested a lot of academic marketing, but not worth the candle so that they have not fully aware of the problem lies. As early as three years ago, has recruited a marketing director, is said to be done for many years of drug sales, and marketing pharmaceutical companies coincided with Tian in transition, for the academic director of marketing for marketing a smatteri